Annual Corporate Profiles 2015-2016

Available online @ AnesthesiologyNews.com

2015-2016

Anesthesia Business Consultants Eagle Pharmaceuticals Edwards Lifesciences MAQUET Medical Systems USA Masimo Mindray MCMahon Publishing

18 19 20 22 24 26 28

Pacira Pharmaceuticals, Inc.

29

Par Sterile Products, LLC

30

PharMEDium

32

Spacelabs Healthcare

34

TeamHealth Anesthesia

36

Teleex

38

2015-2016

th Corporate

28

ANNUAL

Profiles

ANESTHESIA S S BUSINESS US SS CONSULTANTS CO SU S

A

nesthesia Business Consultants, LLC (ABC) is the largest billing and practice management company dedicated to the complex and intricate specialty of anesthesia and pain management. It is both an Anesthesia Quality Institute Preferred Vendor and a Gold Affiliate with the Medical Group Management Association. Tony Mira, ABC’s founder, president and CEO, has maintained a concentration on providing services exclusively to anesthesia and pain management professionals since the company’s inception more than 35 years ago.

ABC distinguishes itself by providing optimal business tools to strengthen business processes and enhance cash flow—all while keeping pace with constant changes in the health care environment. ABC prides itself on the longevity of its client relationships and its ability to customize services to the unique requirements of each practice.

ABC offers its clients innovative billing and reimbursement services, as well as valuable practice management tools and solutions that allow them to realize their own particular strategic visions and business plans.

The ABC Management Advantage ABC distinguishes itself through its focus, operational approach and management structure: • Unlike many competitors who continually redefine their market focus, ABC has remained true to its core market of anesthesiologists, certified registered nurse anesthetists and pain management specialists, enhancing the credibility of its insight and advice.

• ABC believes its relationship with its clients is a true partnership—a partnership in which ABC not only helps improve the billing process, but also helps the group operate more efficiently in the operating room, and more proactively in its relationship with the hospital.

• ABC’s centralized approach allows effective management and oversight, ensuring consistent results.

• Managing a business based on the input and expectations of shareholders does not always result in the most appropriate business decision-making.

Because ABC is privately held, it has much greater flexibility in setting its agenda, managing the business and being responsive to its clients’ needs.

The ABC Service Advantage ABC offers a full range of services designed to meet its clients’ needs, from a specific area of service to an allencompassing solution partner.

Billing and Reimbursement Services Because all processing is centralized, ABC maintains its high standards for quality control and efficiency, resulting in faster claims resolution and higher levels

18

Tony Mira, president and CEO

Anesthesiology News • August 2015

of reimbursement. Extensive management reporting options allow both management and the client to monitor subtle changes in payer mix and reimbursement patterns. Services include: • Front-end edit and claim-scrubber technology • Patient deductible strategies and solutions • Claim underpayment monitoring and reporting

Management Support Services

AT A GLANCE 255 West Michigan Ave. Jackson, MI 49201 (800) 242-1131

WEBSITES www.anesthesiallc.com

No one company is more qualified to furnish critical management information and proactively advise practice decision makers. ABC stands alone in its ability to provide a full range of management support services: • Strategic management • Practice management • Practice consulting • Financial services • Quality management (PQRS/QCDR) • Human resources consulting • Contracting services • Compliance and HIPAA • Education and training

SOCIAL MEDIA

The ABC Technology Advantage

SERVICES

To ensure flexibility with its clients and their varying levels of need, ABC has carefully crafted a portfolio of products to meet client needs during the entire perioperative process.

The most advanced, secure and reliable software designed especially for anesthesia billing and practice management, F1RSTAnesthesia T converts clinical information into claims for reimbursement. This powerful tool supports electronic claims editing to ensure consistently high billing acceptance rates and minimizes manual intervention in payment posting through direct remittance processing. Providers also are able to receive real-time or historical information through F1RSTAnesthesia T ’s web-based technology or advanced data warehousing/data-mining technology.

Joining F1RSTAnesthesia T ’s software strength is a group of carefully crafted service lines that encompass the perioperative process: • Patient portal • Anesthesia information management systems (AIMS) • Postoperative quality • Call scheduling • Patient satisfaction • Patient monitoring The ABC approach to account management can be performed on either a PC or an Apple iPad. The solution requires no interaction with the hospital or surgery center’s servers to host the software. These elements offer an unparalleled platform to streamline and automatically incorporate best practices and clinical protocols to any practice.

• F1RSTAnalytics T provides Real-Time Insight at Your Fingertips. We all know that data help us make better, more educated decisions. But collecting large amounts of data is ineffective without the proper tools to display those insights. Without understanding the context of a specific metric, it can be easily misunderstood and misrepresented.

Full-service billing and practice management firm dedicated exclusively to anesthesiologists and pain management physicians.

http://www.anesthesiallc.com/ publications/blog http://twitter.com/anesthesiallc https://www.facebook.com/ anesthesiallc http://www.linkedin.com/in/ tonymira https://plus.google.com/ 100461134039781832016/posts

EMPLOYEES 850+

Physicians and managers alike require a smooth transition from the clinical, administrative and operational data sets to better understand the true messages that the data are trying to tell.

ABC’s powerful, intuitive F1RSTAnalytics T Key Performance Indicators (KPI) Dashboard helps you quickly understand what’s going on and what you need to focus on.

The F1RSTAnalytics T Accounts Receivable (AR) Dashboard is a set of measures specifically for anesthesia practices. At a glance, the AR Dashboard tells you what you need to know about where and how revenue is generated, and where you may have issues.

• F1RSTClient is a premier client portal that allows clients to securely and seamlessly access ABC’s applications and data, such as F1RSTAnesthesia T and F1RSTAnalytics T . Our F1RSTClient portal gives you complete and secure visibility to your practice’s data through one tool. Because it’s web-based, you can access it anywhere you can launch a browser.

Whether you want to look at patient data in the ledger or review a monthly report or if you’re a user of F1RSTAnalytics T , the F1RSTClient portal provides that easy access through a single, secure tool. Ask your account team about how you can get access and visibility to your data, today.

This corporate profile was reviewed and approved by Anesthesia Business Consultants.

2015-2016

th Corporate

28

ANNUAL

Profiles

EAGLE G PHARMACEUTICALS C U C S

E

agle is a specialty pharmaceutical company focused on developing and commercializing injectable therapeutics, primarily in the areas of critical care, orphan diseases and oncology. Our goal is to improve the lives of customers and patients with optimized formulations through the 505(b)(2) regulatory pathway. We develop proprietary enhancements to FDA-approved drugs while adhering to the principles of innovation, quality, integrity and leadership.

Making Improvements for Patients and Health Care Professionals We recognize that many injectable products used in acute care settings have suboptimal characteristics.

These products may not fully meet the needs of patients and health care professionals. That’s why we work diligently to create enhanced formulations that address these issues.

For instance, some drug formulations have inherent inefficiencies when it comes to preparation. These can include requiring multistep preparation (labor- and time-intensive), the need for a large volume of diluent and the use of numerous vials in an emergency situation.

time-consuming to reconstitute and administer.3,4 Usually several members of the operating room staff are employed in the reconstitution process.2 That’s because a full initial dose for a 100-kg patient may require the reconstitution of 12 or more vials of the conventional dantrolene sodium product.3,4 This can pose a serious problem as the risk for complications increases by over 30% for every 20-minute delay in treatment.5 That’s where RYANODEX® is different: It is formulated to be fast to reconstitute and administer a loading dose.2 RYANODEX® is unlike conventional dantrolene sodium products; one vial provides a full loading dose (2.5 mg/kg) for most patients.1,6 It can be reconstituted and administered by just one health care professional in less than one minute.1,2 This creates the potential to reduce complications resulting from treatment delays.1,2,5,7

Indication RYANODEX® is indicated for the treatment of malignant hyperthermia in conjunction with appropriate supportive measures and for prevention of malignant hyperthermia in patients at high risk.

Our Products

Important Safety Information

At Eagle, we believe that our products have the potential to create a new standard for treatment. Our optimized reformulations of injectable drugs aim to: • Enable faster reconstitution and administration in most cases • Reduce the fluid volume infused into patients, which may reduce the potential for complications relating to fluid-volume overload • Reduce drug infusion time • Optimize dose regimen

RYANODEX® (dantrolene sodium) for injectable suspension is not a substitute for appropriate supportive measures in the treatment of malignant hyperthermia, including: • Discontinuing triggering anesthetic agents • Increasing oxygen • Managing metabolic acidosis • Instituting cooling when necessary • Administering diuretics to prevent late kidney injury due to myoglobinuria (the amount of mannitol in RYANODEX® is insufficient to maintain diuresis) Precautions should be taken when administering RYANODEX® preoperatively for the prevention of malignant hyperthermia, including monitoring vital signs, avoiding known triggering agents, and monitoring for early clinical and metabolic signs of malignant hyperthermia that may indicate additional treatment is needed.

The administration of dantrolene sodium is associated with loss of grip strength and weakness in the legs,

Improving Malignant Hyperthermia Treatment A prime example of how Eagle has improved an area of treatment is RYANODEX® (dantrolene sodium) for injectable suspension. Our novel formulation of dantrolene sodium is indicated for the treatment of malignant hyperthermia in conjunction with appropriate supportive measures.1,2 A major issue with conventional dantrolene sodium products is that they are often

This corporate profile was reviewed and approved by Eagle Pharmaceuticals.

AT A GLANCE 50 Tice Boulevard, Suite 315 Woodcliff Lake, NJ 07677

WEBSITE http://eagleus.com

as well as drowsiness, dizziness, dysphagia, dyspnea and decreased inspiratory capacity. Patients should not be permitted to ambulate without assistance until they have normal strength and balance. Care must be taken to prevent extravasation of RYANODEX® into the surrounding tissue due to the high pH of the reconstituted RYANODEX® suspension and potential for tissue necrosis.

This is not a complete list of potential adverse events associated with RYANODEX® for injectable suspension.

Please see full Prescribing Information for a complete list.

To report negative side effects associated with RYANODEX®, please call (855) 318-2170. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call (800) FDA-1088.

For more information about Eagle Pharmaceuticals, visit Eagleus.com.

To see the RYANODEX® difference, visit Ryanodex. com.

References 1. RYANODEX [package insert]. Woodcliff Lake, NJ: Eagle Pharmaceuticals, Inc.; 2014.

2. Data on file. Eagle Pharmaceuticals, Inc. 3. Dantrium Intravenous [package insert]. Rochester, MI: JHP Pharmaceuticals, LLC; 2008.

4. Revonto [package insert]. Louisville, KY: US WorldMeds, LLC; 2011.

5. Riazi S, Larach MG, Hu C, et al. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg. 2014;118(2):381-387.

6. Managing an MH crisis. Malignant Hyperthermia Association of the United States website. http://www.mhaus.org/healthcareprofessionals/managing-a-crisis. Accessed June 10, 2015.

7. Brandom BW. Cases from the North American MH Registry/ MHAUS [1992 through 2012].

Anesthesiology News • August 2015

19

2015-2016

th Corporate

28

ANNUAL

Profiles

EDWARDS W S LIFESCIENCES SC C S A choice of hemodynamic monitoring options to meet your clinical needs.

E

dwards Lifesciences’ advanced hemodynamic monitoring and management systems enable individualized hemodynamic optimization. The systems provide clarity into patient status, helping clinicians to make more informed volume management decisions in their moderate- to high-risk surgery patients.

Edwards’ extensive line of hemodynamic management sensors, catheters and monitoring tools enable clinicians’ to make proactive clinical decisions in the operating room (OR) and ICU. Hemodynamic instability may increase with more complicated or invasive procedures and with the presence of various comorbidities. As a result, clinicians’ hemodynamic monitoring needs and preferences may vary with the complexity of each procedure and patient.

Edwards provides a range of monitoring options that can be used in perioperative goal-directed therapy (PGDT) protocols to maintain patients in the optimal volume range during moderate- to high-risk surgery. Further, the Edwards Enhanced Surgical Recovery Program can help implement hemodynamic optimization through PGDT in moderate- to high-risk surgery procedures.

The noninvasive ClearSight system extends the clarity of continuous hemodynamic monitoring to moderateand high-risk surgery patients including elderly or obese patients in whom an arterial catheter would not typically be placed—enabling you to make more informed decisions about volume administration in your patients.

Parameters monitored include: Stroke Volume (SV), Stroke Volume Variation (SVV), Cardiac Output (CO), Continuous Blood Pressure (cBP).

The minimally invasive FloTrac sensor connects to an existing arterial line to continuously provide dynamic,

flow-based parameters that can be used in PGDT protocols. It is a practical solution for making informed volume management decisions in your moderate- and high-risk surgery patients. The FloTrac sensor has been chosen by clinicians more than any other minimally invasive volume management solution to monitor over 2.5 million patients worldwide.* The PreSep oximetry catheter continuously measures a patient’s central venous oxygen saturation, providing an earlier and more global view of tissue oxygenation and consumption.

The Swan-Ganz pulmonary artery catheter with advanced monitoring capability provides a single, integrated hemodynamic profile for the most complex patients. The Edwards Swan-Ganz catheter remains the leading pulmonary artery catheter for surgical, critical care and trauma patients worldwide.* The EV1000 clinical platform presents the physiologic and hemodynamic status of the patient in an intuitive and meaningful way. Designed to work with the ClearSight finger cuff, FloTrac sensor and PreSep oximetry catheter, the platform offers the scalability and adaptability for both the OR and ICU. Edwards VAMP (Venous Arterial blood Management Protection) closed-loop blood sampling system is a needleless, closed blood sampling system designed to reduce infection,1,2 needle sticks3 and blood waste4,5 associated with conventional blood sampling methods. The TruWave pressure transducer can be paired with the VAMP system for combined accuracy and reliability with the safety of a single, seamless foundational monitoring solution.

Edwards offers an extensive line of education and support tools to facilitate the integration of advanced

AT A GLANCE One Edwards Way Irvine, CA 92614 (800) 424-3278; (949) 250-2500 CriticalCare@Edwards.com www.Edwards.com/ESR Or www.Edwards.com/CCeducation

PRODUCTS Hemodynamic monitoring systems including the ClearSight system; FloTrac sensor; PreSep oximetry catheter; Swan-Ganz pulmonary artery catheter; and EV1000 clinical platform. Pressure monitoring solutions including the TruWave pressure transducer and VAMP (Venous Arterial blood Management Protection) system.

hemodynamic monitoring in acute care settings. Visit www.Edwards.com/CCeducation to review perioperative patient simulations, simulated case studies, product animations and more. Or, visit youtube.com/ECCE4you for OR- and ICU-specific playlists.

With more than 40 years of collaborating with you to advance patient care, Edwards is committed to developing solutions that provide the clarity and control to make more informed decisions.

1. Walrath JM, et al. Stopcock: bacterial contamination in invasive monitoring systems. Heart Lung. 1979:8(1):100-104.

2. Shinozaki T, et al. Bacterial contamination of arterial lines. A prospective study. JAMA. 1983:249(2):223-235.

3. Tan L, et al. Report of the Council on Scientific Affairs: preventing needlestick injuries in health care settings. JAMA Intern Med. 2001:61(7):929-936.

4. Barth MD, et al. Blood conservation: what is current blood draw practice? J Infus Nurs. 2013;36(5)323-328.

5. Smoller BR, et al. Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. Am J Clin Pathol.

1989:91(6):701-703. *Data on file.

Caution: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

The EV1000 clinical platform provides a variety of informative screens from which to choose to provide immediate insight and guide your therapeutic interventions. The platform also allows you to select the parameters most significant for your monitoring requirements, enabling you to make more informed decisions and determine the best course of action.

20

Anesthesiology News • August 2015

Edwards, Edwards Lifesciences, the stylized E logo, Enhanced Surgical Recovery Program, ClearSight, EV1000, FloTrac, PreSep, Swan-Ganz, TruWave and VAMP are trademarks of Edwards Lifesciences Corporation.

This corporate profile was reviewed and approved by Edwards Lifesciences.

Clarity gives you the control to make more informed decisions.

ClearSight Noninvasive System CO, SV, SVV, SVR, cBP* FloTrac Minimally-Invasive System CO, SV, SVV, SVR Swan-Ganz System CCO, RVEDV, RVEF, SvO2

Edwards Lifesciences’ range of hemodynamic monitoring solutions

The Edwards Enhanced Surgical Recovery Program can help you

provides key flow parameters shown to be more informative in

implement PGDT today. PGDT can help ensure yourr patients are

determining fluid responsiveness than pressure-based parameters.

consistently maintained in the optimal volume range. ge ge.

Each offers continuous information which may be used in

Know more. Know now. To see how you can n individualize therapy under more conditions co ns visit Edwards.com/ESRsolutions

1

Perioperative Goal-Directed Therapy (PGDT) to hemodynamically optimize your moderate to high-risk surgery patients.

1. Michard F, Biais M. Rational fluid management: dissecting facts from fiction. Br J Anaesth 2015 * Continuous Blood Pressure For professional use. CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use s for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

Edwards Lifesciences devices placed on the European market, meet the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC, 3/ and bear the CE marking of conformity.

Edwards, Edwards Lifesciences, the stylized E logo, ClearSight, Enhanced Surgical Recovery Program, FloTrac and Swan-Ganz are trademarks of Edwards ds Lifesciences Corporation. All other trademarks are the property of their respective owners. Š 2014 Edwards Lifesciences Corporation. All rights reserved. AR11787

Edwards Lifesciences | edwards.com

One Edwards Way | Irvine, California 92614 USA

Switzerland | Japan | China | Brazil | Australia | India

2015-2016

th Corporate

28

ANNUAL

Profiles

MAQUET QU MEDICCAL SSYSTEMS S S US USA The gold standard

M

AQUET Medical Systems USA is a market-leading medical device company whose mission is to help improve patient outcomes and quality of life through advanced technology. MAQUET offers comprehensive products and therapeutic solutions for the hybrid operating room (OR), ICU and general OR, as well as for patient transport.

MAQUET has a long history of innovation in anesthesia, beginning with the introduction of its first anesthesia machine in 1981. Since then, the company has delivered almost 11,000 units to hospitals worldwide. It also has set market standards with its high-performance SERVO ventilation platform for more than 40 years. The company has a deep understanding of mechanical ventilation and the challenges facing anesthesiologists today.

Not only are patient demographics constantly shifting, but surgical procedures are becoming more complex on a daily basis, necessitating advanced technology to ensure optimal patient care. MAQUET invests significantly in research and development to meet the changing needs of hospitals and anesthesiologists, and to ensure that it can provide anesthesia products that offer high-performance ventilation and support capabilities.

MAQUET’s flagship anesthesia product, the FLOW-i Anesthesia System® with high-performance SERVO ventilation, offers true ICU ventilator performance and effective anesthesia delivery from the same unit.

AT A GLANCE High-Performance Ventilation Features • Set tidal volume is accurately delivered even under high abdominal and thoracic pressures, helping to avoid hypoventilation.

• Fast rise time and high flow rates adapt to varying inspiratory demand in the presence of increasing airway pressure.

• Sensitive triggering improves synchrony in pediatric patients and those with decreased respiratory drive.

• Consistent and accurate positive end-expiratory pressure (PEEP) levels are maintained.

• Controlled pressure drop during expiration decreases expiratory resistance and work of breathing, in addition to minimizing auto-PEEP at higher respiratory rates.

Advanced Design and Technology The FLOW-i system’s ergonomically designed, fully electronic platform and touchscreen interface are easy to use and upgrade for enhanced workflow today and in the future. The open architecture allows hospitals to add the patient monitor and data management system of their choice and easily integrate future software and hardware advances into the system—increasing cost efficiency by avoiding the need for costly equipment replacement or upgrades. In addition, clinician ease of use and comfort are engineered into every FLOW-i machine with its height adjustability, movable arms and integrated table light.

U.S. HEADQUARTERS MAQUET Medical Systems USA 45 Barbour Pond Dr. Wayne, NJ 07470 (888) 627-8383 www.maquetusa.com

PRODUCTS Intensive care ventilators and anesthesia machines, suite of cardiovascular products (for intra-aortic balloon counterpulsation, cardiac assist, coronary artery bypass surgery, aortic and peripheral vascular surgery, and extracorporeal circulation), flexible room design for OR and ICU, OR tables, lights and ceiling supply units and OR integration

EMPLOYEES 6,000 MAQUET employees in 50 international sales and service organizations, as well as a network of more than 280 sales representatives

PRESIDENT AND CEO Raoul Quintero

FLOW-i Anesthesia System With High-Performance SERVO Ventilation MAQUET’s FLOW-i Anesthesia System seamlessly combines high-performance SERVO ventilation with precise anesthesia delivery to help meet the needs of all patients. These include the most challenging cases, such as obese patients with high abdominal and thoracic pressures, older patients suffering from multiple medical conditions, the critically ill and the smallest neonates.

FLOW-i reacts quickly to changing parameters, as the low internal system volume enables rapid changes in gas concentration when needed, and facilitates fast wash-in and wash-out of the anesthetic agent. This process helps to minimize waste and unnecessary use of the agent through precise delivery technology.

Innovative Volume Reflector™ Re-Breathing Technology The FLOW-i system features the innovative Volume Reflector technology to ensure that the breathing circuit will never be empty and that ventilation will remain uninterrupted regardless of surgical constraints, changing conditions or patient position. The re-breathing technology consists of a rigid reservoir to increase the re-breathing as well as maintain high ventilation performance. It replaces both the traditional bellows and the piston technologies in older systems. Oxygen-driven by design, the Volume Reflector helps to minimize the risk for delivering a potentially dangerous hypoxic mixture in the presence of leaks during low-flow anesthesia.

With the new O2Guard, an automatic increase of oxygen will occur if the system detects too-low oxygen at the Y-piece. FLOW-i anesthetic agent injection vaporizers are fully electronic, lightweight and can be refilled while slotted in the machine, even when still in use. The agent delivery is mainly on inspiration, leading to less use of anesthetic agents.

Learn More To learn more about the MAQUET FLOW-i Anesthesia System, visit www.maquetusa.com.

22

Anesthesiology News • August 2015

This corporate profile was reviewed and approved by MAQUET Medical Systems USA.

Maquet is a registered trademark of Maquet GmbH • FLOW-i is a registered trademark of Maquet Critical Care AB. • Copyright Maquet Medical Systems USA or its affiliates. • CAUTION: Federal (US) law restricts this device to sale by or on the order of a physician. Refer to Instructions for Use for current indications, warnings, contraindications, and precautions. MCV00030576 REVA

easier.

FLOW-i makes responsive support easy. ®

Taking care of your patients is easier now that advanced ICU ventilator performance and precise anesthesia delivery are available in one patient-friendly unit: FLOW-i.

Ease-of-use and ergonomics are engineered into each of our three FLOW-i models, which feature movable arms and the capacity to work from any angle, enabling better supervision of the patient. Designed to be in sync with the clinician, the system combines seamless technology with an intuitive touch screen, simple navigation, and adaptability with existing monitoring and data systems. It also reacts quickly to changing conditions, allowing you and your patients to truly breathe easy.

Maquet is proud to have partnered with our customers to reinforce our commitment to patients by supporting Make-A-Wish® with a donation in the amount of $150,000 to help fulfill the wishes of children with life-threatening medical conditions across the USA. For more information about Make-A-Wish visit wish.org.

FLOW-i: Innovative simplicity by design.

www.maquetusa.com

2015-2016

th Corporate

28

ANNUAL

Profiles

MASIMO S O Taking noninvasive monitoring to new sites and applications

F

or more than 25 years, Masimo has focused on a singular mission—helping clinicians improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications.

Continuing to Set the Benchmark for Oxygenation Monitoring During Challenging Conditions Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry helps clinicians monitor more than 100 million patients a year and is the primary pulse oximetry technology for eight of the top 10 hospitals on the U.S. News & World Report Best Hospitals Honor Roll for 2014-2015. Masimo SET® delivers accurate, reliable oxygenation measurements when patients are moving or have low blood flow—reducing false alarms by over 95% and expanding true alarm detection to over 97%.1,2

rainbow® Technology rainbow® technology allows noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively. The rainbow SET® suite includes: • Total Hemoglobin (SpHb®) • Methemoglobin (SpMet®) • Carboxyhemoglobin (SpCO®) • Oxygen Content (SpOC™) • Acoustic Respiration Rate (RRa®)

Helping Clinicians Noninvasively Measure Hemoglobin SpHb ® offers real-time visibility to whether hemoglobin is: • Stable and the clinician may otherwise think hemoglobin is dropping.

• Rising and the clinician may otherwise think hemoglobin is not rising fast enough.

• Dropping and the clinician may otherwise think hemoglobin is stable.

Respiration Rate Monitoring With rainbow Acoustic Monitoring™ The Anesthesia Patient Safety Foundation (APSF) recommends continuous oxygenation and ventilation monitoring for patients receiving opioid-based pain medications.3 However, methods for respiration rate monitoring are limited by accuracy and patient tolerance. While Masimo offers award-winning capnography solutions, we also offer rainbow Acoustic Monitoring™ (RAM™) with RRa®, which can help clinicians monitor patient breathing in postsurgical and conscious sedation situations.4

24

Anesthesiology News • August 2015

AT A GLANCE

Surveillance, Remote Monitoring, and Connectivity on Medical-Surgical Units With Masimo Patient SafetyNet™* Patient SafetyNet™ along with Iris™ Connectivity through the Root® patient monitoring and connectivity platform offers a new level of interoperability designed to enhance clinician workflows and reduce the cost of care from operating rooms to medical-surgical units. Existing approaches for device interoperability typically require separate hardware, software and/or network infrastructure, which can clutter the patient room, increase complexity, burden IT management and increase costs.

Root® with Iris™ enables Patient SafetyNet™ to intake data from all devices connected to the patient, acting as an in-room patient monitor and connectivity hub.

Alarms and alerts for all devices are seamlessly forwarded to the patient’s clinician and all device data can be transferred to the patient’s electronic medical record (EMR). To simplify documentation of patient data during rounds, Root® enables clinicians to easily verify and send patient vitals, as well as all connected medical device information, to the EMR directly from Root®.

52 Discovery Irvine, CA 92618 (949) 297-7000 www.masimo.com

PRODUCTS Masimo SET® pulse oximetry and sensors; rainbow® Pulse CO-Oximetry and sensors; Root® patient monitoring and connectivity platform; rainbow Acoustic Monitoring™; SedLine® brain function monitoring; Patient SafetyNet™ remote monitoring and notification system.

MISSION STATEMENT Improving patient outcomes and reducing cost of care by taking noninvasive monitoring to new sites and applications.

EMPLOYEES 3,500

Radius-7™ – Breakthrough Measurements in a Patient-Worn Monitor

FOUNDER AND CEO Joe Kiani

Root® with Radius-7™ offers a wearable, wireless monitor with Masimo’s breakthrough Masimo SET® and RAM™ technologies. Radius-7™ provides continuous monitoring with freedom of movement.

Studies have shown that patient mobility is a key factor in more rapid patient recovery.5 Radius-7™ allows clinicians to continuously monitor their patients when they are mobile. ®

Sedation Monitoring With SedLine

SedLine® brain function monitoring provides four channels of electroencephalography (EEG), Spectral

displays and processed EEG parameters to help clinicians better understand the effects of anesthesia on the brain. SedLine® measures the effects of anesthesia by monitoring both sides of the brain’s electrical activity. * Use of the trademark PATIENT SAFETYNET™ is under license from University Health System Consortium.

References 1. Shah N, et al. Performance of three new-generation pulse oximeters during motion and low perfusion in volunteers. J Clin Anesth.

2012:24(5):385-391.

2. Taenzer AH, et al. Impact of pulse oximetry surveillance on rescue events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology. 2010;112(2):282-287.

3. Stoelting RK, et al. APSF Newsletter. 2011. www.apsf.org.

4. Ramsay M, et al. The accuracy, precision and reliability of measuring ventilator rate and detecting ventilator pause by rainbow acoustic monitoring and capnometry. Anesth Analg. 2013;117(1):69-75.

5. Needham D, et al. Early physical medicine and rehabilitation for patients with acute respiratory failure: a quality improvement project. Arch Phys Med Rehabil. 2010;91(4):536-542.

This corporate profile was reviewed and approved by Masimo.

Track Hemoglobin Changes in Real Time with Noninvasive and Continuous Hemoglobin (SpHb ) Monitoring ®

Root® also offers analog view. view

Real-time visibility to whether hemoglobin is: > Stable and the clinician may otherwise think hemoglobin is dropping > Rising and the clinician may otherwise think hemoglobin is not rising fast enough > Dropping and the clinician may otherwise think hemoglobin is stable

To learn more, visit www.masimo.com/hemoglobin

© 2015 Masimo. All rights reserved.

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions.

SpHb monitoring is not intended to replace laboratory blood testing. Blood samples should be analyzed by laboratory instruments prior to clinical decision making.

STG-0088A/CO-022075

www.masimo.com

2015-2016

th Corporate

28

ANNUAL

Profiles

MINDRAY “healthcare within reach”

A

s a leading developer, manufacturer and marketer of anesthesia and life support systems, patient monitors, in vitro diagnostics, and medical imaging products, Mindray is dedicated to delivering the highest-quality medical instrumentation to a global market. Founded in 1991 and headquartered in Shenzhen, China, Mindray is the third-largest manufacturer of anesthesia systems and patient monitors worldwide. In 2008, Mindray acquired Datascope’s patient monitor business, which has been a leader in patient monitoring products since it was founded in 1964. With more than 8,000 employees and R&D centers on three continents, Mindray offers a broad range of innovative solutions designed to contain costs while ensuring the highest-quality products for patient care. Today, Mindray’s products and services can be found in healthcare facilities in more than 190 countries. Inspired by the needs of customers, Mindray adopts advanced technologies and transforms them into accessible innovation, bringing healthcare within reach.

Mindray’s outstanding sales professionals and clinical education specialists provide your staff with comprehensive, on-site training and in-service. Mindray’s dedicated field service and in-house technical support organization is one of the largest direct service teams in the industry. Learn how Mindray can help you maximize your resources with some of the most advanced and accessible medical equipment in the industry.

Anesthesia Delivery Systems The A-Series platform combines the simplicity of traditional anesthesia delivery with advanced technology and features. Award-winning design, an intuitive user interface and advanced ICU quality ventilation modes support effective care across a wide range of patients. The 15-inch color touchscreen is designed for comfortable interaction and visibility, allowing clinicians to easily select ventilation modes and adjust settings. Automatic compliance and fresh gas compensation maintain accurate tidal volumes while the temperature-controlled breathing system virtually eliminates internal condensation.

The new A7 Anesthesia Workstation features electronic gas control to ensure precise gas flow dynamics with accurate and responsive support for both clinical and cost saving requirements, including low flow anesthesia delivery.

The A5 Anesthesia System comes standard with comprehensive ventilation modes including VCV, PCV with Volume Guarantee, Pressure Support, SIMV-VC, SIMVPC, spirometry loops, high-pressure O2 port, central locking brake, mounting rails, adjustable workspace lighting, and an innovative backup control touchpad. Optional integrated gas analysis with dual-agent auto-ID, agebased MAC values and capnography further enhance the ability to support high-acuity requirements. The A3 Anesthesia System provides many of the features and benefits of an advanced anesthesia delivery system for the outpatient and mid-acuity environment.

A-Series safety features include an auxiliary oxygen and air-flow meter that delivers blended gas through the nasal cannula, decreasing the potential risk for surgical

26

Anesthesiology News • August 2015

AT A GLANCE fire. The A-Series delivers fresh gas and anesthetic agent in the event of total loss of power.

Anesthesia Connectivity Connectivity and interoperability are at the core of the A-Series Anesthesia System platform. Since the ARRA and HITECH programs passed in 2009, the healthcare industry has seen the adoption of electronic health record (EHR) and anesthesia information management systems in record numbers. Mindray has been a leader, developing integrated solutions for seamless data exchange. Serial communication, Ethernet communication or both can be deployed using industry standard HL7 protocols. Through this integration, the A-Series Anesthesia Systems are well equipped to meet the interoperability requirements for integration engines and EHR systems.

Anesthesia Consumables Mindray is now a one-source provider of anesthesia equipment and consumable products, offering a competitive line of quality breathing circuits, anesthesia circuit kits, breathing masks, laryngeal airway masks, filters and gas monitoring accessories.

Powerful Technology in Patient Monitoring And Network Solutions

NORTH AMERICAN HEADQUARTERS Mindray North America 800 MacArthur Blvd.

Mahwah, NJ 07430

MINDRAY GLOBAL HEADQUARTERS Keji 12th Road South High-Tech Industrial Park Nanshan, Shenzhen 518057 P.R. China

PRODUCTS AVAILABLE IN THE UNITED STATES Anesthesia delivery systems, breathing circuits, laryngeal airway masks, ultrasound imaging, full line of patient monitors, central stations, telemetry and networking solutions.

EMPLOYEES 8,000 worldwide

PRESIDENT MINDRAY NORTH AMERICA George Solomon

The new Passport line offers a broad range of patient monitoring capabilities in a robust, modular design. The Passport 17M’s large 17-inch touchscreen display is most appealing in the operating room, where visibility and convenience are essential. The Passport 12M’s flexibility and modularity combine with a 12-inch touchscreen display to offer a complementary solution for postoperative areas. Supporting up to eight invasive pressures and features such as auto-ID of anesthetic agents and gases, and BIS monitoring, the Passport 12M and 17M represent a powerful combination of advanced functionality and extraordinary value.

The newly introduced T1 is a module and monitor all in one. Used as a multi-parameter module in the Passport 12M and 17M monitors, the T1 provides 3/5/12 lead ECG, 2 IBP, SpO2, temperature and NIBP, satisfying

many monitoring requirements in the OR environment. For use as a transport monitor, simply remove the T1 from the Passport monitor and go. The versatile 2-lb package, with its brilliant 5-inch touchscreen display, allows continuous monitoring from procedure to recovery.

Ultrasound Imaging Mindray continues to provide innovative solutions for point-of-care environments with the introduction of the TE7 Touch Enabled Ultrasound System. The new intuitive touchscreen-based system, with superior imaging, supports rapid and confident diagnosis in the OR and at the bedside. Intuitive gesture controls and focused anesthesia exams minimize the user learning curve, with no need to navigate a knob-cluttered keyboard. Simply select an exam preset and the relevant functions become accessible. With its advanced touchscreen interface and expanded features, including iNeedle™ visualization and dedicated nerve exam presets, the TE7 is an ideal system for nerve block and pain management. With the addition of cardiac functionality and the TEE transducer, the TE7 also meets the demands of the CVOR environment.

Learn More To learn more about how Mindray can help you realize more value in your anesthesia solutions, contact your local sales specialist at (800) 288-2121, or visit us at www.mindray.com.

This corporate profile was reviewed and approved by Mindray.

™

A N E S T H E S I A W O R K S TAT I O N

it’s your world

Transport Monitor

Touchscreen Ultrasound

Multi-parameter Monitors

Anesthesia Consumables

Mindray North America, 800 MacArthur Blvd., Mahwah, NJ 07430 800.288.2121 www.mindray.com

To support you in the care of your patients, Mindray provides a broad range of solutions across the perioperative environment. From advanced A-Series anesthesia delivery systems, to a new line of single-use breathing circuits and kits, versatile patient monitors, flexible transport solutions and portable point-of-care ultrasound systems—Mindray offers a world of high quality, easy to use, innovative, yet affordable solutions that help simplify the challenges of your complex world.

2015-2016

th Corporate

28

ANNUAL

Profiles

MCMAHON O PUBLISHING U S G

M

cMahon Publishing was founded in 1972

by Raymond E. McMahon and has grown to become one of the nation’s largest family-owned medical publishers.

McMahon publishes a broad array of medical newsmagazines in various specialties, including anesthesiology, gastroenterology, general surgery, hospital and specialty pharmacy, infectious diseases, pain medicine and oncology. The combined circulation of McMahon publications is approximately 300,000 doctors and pharmacists.

Foremost among McMahon publications is Anesthesiology News. Now in its 41st year, Anesthesiology News has been the best-read publication for the specialty for the past 18 years, according to Kantar Media. Nearly 80% of the 47,220 U.S.-based anesthesiologists read this publication each month.

McMahon newsmagazines are accompanied by a full line of digital media, including websites, mobile sites, iPad apps, e-newsletters, digital editions, multimedia and social media.

McMahon publishes: • Anesthesiology News - Anesthesiology News Buyer’s Guide - Anesthesiology News Guide to Airway Management - Anesthesiology News Special Edition • Clinical Oncology News • Gastroenterology & Endoscopy News • General Surgery News • Infectious Disease Special Edition • Pain Medicine News • Pharmacy Practice News • Specialty Pharmacy Continuum

AT A GLANCE 545 W. 45th St., 8th Floor New York, NY 10036 (212) 957-5300 www.mcmahonmed.com www.anesthesiologynews.com @anesthesianews anesthesiologynews +anesthesiologynews

PRODUCTS Medical newsmagazines, special editions, custom publishing, educational reviews, multimedia and more.

EMPLOYEES 60

PUBLISHER AND MANAGING PARTNER Raymond E. McMahon

GENERAL MANAGER, PARTNER Matthew McMahon

ANESTHESIOLOGY NEWS Editorial Director James Prudden Associate Editor Martin Leung Senior Group Publication Director Richard Tuorto Manager, Publication Sales Angela Labrozzi Sales Associate, Classifieds Craig Wilson Production Manager Martin Barbieri Art Director Blake Dennis

®

® ®

®

®

®

for iPad REPORT

28

Anesthesiology News • August 2015

This corporate profile was reviewed and approved by McMahon Publishing.

2015-2016

th Corporate

28

ANNUAL

Profiles

PACIRA C PHARMACEUTICALS, C U C S, INC. C

P

acira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products to address the needs of acute care practitioners and their patients. Pacira is driven by a dynamic workforce committed to optimizing patient care and satisfaction in the acute care setting, with a special focus on improving outcomes in postsurgical pain management.

A Proprietary Drug Delivery Platform The cornerstone of the Pacira product portfolio is DepoFoam®, a proprietary drug delivery platform designed to extend a medication’s duration of action without altering its molecular structure. The DepoFoam carrier matrix is made up of multivesicular liposomes that encapsulate a drug. Each chamber is separated by lipid membranes that naturally erode to release the drug over a desired period of time.

use, the burden of opioids has reached epidemic proportions.2,3 The use of opioids for postsurgical pain has opened the floodgates, adding a cascade of new users to the 5.1 million Americans who already abuse prescription painkillers every day.4 Pacira is committed to working to address this growing societal burden by providing clinicians with a nonopioid option to control pain and reduce opioid requirements in the immediate postsurgical setting, when effective, consistent analgesia is most critical. The company’s efforts are buoyed by a groundswell movement led by government and independent health care organizations that are recommending a shift to opioid-sparing pain management regimens in order to mitigate patient exposure to unwanted and potentially severe side effects, including abuse, addiction and overdose.

Discovery, innovation and proprietary expertise are the hallmarks of the Pacira competitive advantage. The company not only holds the exclusive rights to and expertise in DepoFoam, but owns the unique distinction of being the only company in the world with the ability to manufacture DepoFoam-based products, such as EXPAREL, on a large commercial scale. With steadily increasing demand and a growing list of potential clinical applications, Pacira and EXPAREL are poised to become vital fixtures in the postsurgical pain management arena.

For more information about Pacira Pharmaceuticals Inc., visit www.pacira.com.

A First of Its Kind, Single-Dose Local Analgesic

Important Safety Information For EXPAREL

In 2012, Pacira successfully launched EXPAREL® (bupivacaine liposome injectable suspension)*, the first and only DepoFoam-based local analgesic. Indicated for single-dose administration into the surgical site to produce postsurgical analgesia, EXPAREL provides longlasting pain control that reduces opioid requirements without the need for catheters or pumps.

EXPAREL is contraindicated in obstetrical paracervical block anesthesia. EXPAREL has not been studied for use in patients younger than 18 years of age.

Non–bupivacaine-based local anesthetics, including lidocaine, may cause an immediate release of bupivacaine from EXPAREL if administered together locally. The administration of EXPAREL may follow the administration of lidocaine after a delay

With 99% of patients receiving postsurgical opioids1 and one in 15 of those patients going on to long-term

5 Sylvan Way Parsippany, NJ 07054 (973) 254-3560 www.Pacira.com For more information on EXPAREL, visit www.EXPAREL.com.

For medical inquiries related to EXPAREL, contact Medical Information at medinfo@pacira.com or (855) RX-EXPAREL (855-793-9727).

The Pacira Advantage

*Pivotal studies have demonstrated the safety and efficacy of EXPAREL in patients undergoing hemorrhoidectomy and bunionectomy procedures.

Shifting the Postsurgical Pain Management Paradigm

AT A GLANCE

This corporate profile was reviewed and approved by Pacira Pharmaceuticals, Inc.

of 20 minutes or more. Other formulations of bupivacaine should not be administered within 96 hours after administration of EXPAREL. Monitoring of cardiovascular and neurologic status as well as vital signs should be performed during and after injection of EXPAREL, as with other local anesthetic products.

Because amide-type local anesthetics, such as bupivacaine, are metabolized by the liver, EXPAREL should be used cautiously in patients with hepatic disease.

Patients with severe hepatic disease, because of their inability to metabolize local anesthetics normally, are at a greater risk for developing toxic plasma concentrations.

In clinical trials, the most common adverse reactions (incidence ≥10%) following EXPAREL administration were nausea, constipation and vomiting.

In the hemorrhoidectomy study, there was a cumulative decrease in opioid consumption over the 72-hour study period, the clinical benefit of which was not demonstrated.

References 1. Kessler ER, et al. Pharmacotherapy.

2013;33(4):383-391.

2. Carroll I, et al. Anesth Analg. 2012;115(3):694-702.

3. Alam A, et al. Arch Intern Med. 2012;172(5):425-430.

4. National Institutes of Health. Popping pills: prescription drug abuse in America. http://www.drugabuse.gov/related-topics/trends-statistics/infographics/ popping-pills-prescription-drug-abuse-in-america.

Updated January 2014. Accessed June 15, 2015.

PP-EX-US-0927

Anesthesiology News • August 2015

29

2015-2016

th Corporate

28

ANNUAL

Profiles

PAR STERILE S PRODUCTS, O UC S, LLCC “Providing patients and customers with uncompromising quality and value.”

One Ram Ridge Road Chestnut Ridge, NY 10977

Quality You Can Depend On The legacy of Par Sterile Products reaches back to the birth of the American pharmaceutical industry at the turn of the 20th century. Our Rochester, Mich., location represents one of the landmark manufacturing facilities in the history of our industry. Our iconic brands such as Aplisol® and Adrenalin® have been relied upon by physicians and patients for decades. While proud of our heritage, we are even prouder of the great things we are accomplishing today. In an injectables world frequently plagued by compliance issues and product shortages, Par Sterile Products stands as a highly regarded partner with exemplary trade service levels and an impeccable record of regulatory compliance. Every week in America, more than 1 million Par prescriptions are dispensed, including Par Sterile Products. In return for the trust that is placed in us, we are committed to providing products of uncompromising quality. In fulfilling this mission, we deliver value to our customers and the physicians and patients who rely on us.

Partners for Health Care Excellence Par Sterile Products, LLC, a subsidiary of Par Pharmaceutical, Inc., is at the forefront of developing, manufacturing, marketing and distributing safe, innovative and cost-effective branded and generic aseptic injectable pharmaceuticals that help improve patient quality of life.

We also provide contract manufacturing services to our partners in the biopharmaceutical and pharmaceutical industries. Today, our company’s sales place it among the top five largest generic pharmaceutical companies in the United States. At Par Sterile Products, our most important resource is the talent and dedication of our nearly 500 employees, each of whom is part of a culture that values integrity, customer focus, teamwork and performance.

AT A GLANCE

www.parsterileproducts.com

CUSTOMER SERVICE (800) 828-9393 Option 5, Option 2

DRUG SAFETY/MEDICAL INFORMATION (800) 828-9393 Option 3

CHIEF EXECUTIVE OFFICER Paul Campanelli

Promising Product Pipeline Par Sterile Products currently markets a portfolio of 16 specialty injectable products, including Vasostrict®, Brevital®, Dantrium®, Pitocin® and dexmedetomidine.

Since 2012, Par Sterile Products has launched 12 new products. We possess one of the most promising new product pipelines in the injectable space, having developed a pipeline of 34 products, 12 of which have been submitted for FDA approval. We expect at least a half-dozen ANDA filings annually, fueled by our commitment to investment in research and development.

At Par Sterile Products, we are large enough to maintain a significant trade presence, yet agile enough to provide maximum attention to our customers, and we remain poised to continue our impressive track record of success. For more information, please visit www.parsterileproducts.com.

PAR—People Achieving Results!

PSPM01 0515

30

Anesthesiology News • August 2015

This corporate profile was reviewed and approved by Par Sterile Products, LLC.

®

DANTRIUM IV

(dantrolene sodium for injection) Dantrium® IV from Par Sterile Products, LLC offers the benefits that a well-managed facility needs to be effectively prepared.

Shelf Life 36-month shelf life* may result in more time between required re-orders.

Cost-Competitive Pricing

Priced comparatively to competitor products†

Emergency orders Dantrium® IV is available for emergency orders and can be ordered: s AS DROP SHIP s AS DIRECT PURCHASE s THROUGH LOCAL WHOLESALERS AND DISTRIBUTORS

To order Dantrium® IV from Par Sterile Products, LLC., callll 800-828-9393 800 828 9393 andd select l t option ti 6 or email dantriumcustomerorders@parpharm.com.

*Dantrium® IV has 36 month shelf life from manufacturing point. There is always some lag period between manufacturing date and when the product ships to the end user, which varies when the order is placed. † Cost savings are based on MHAUS recommendation of storing 36 Dantrium® IV vials compared with an equivalent dose of competitor products, using WAC price per vial.

For more information on Dantrium® IV and for Full Prescribing Information please visit www.dantrium.com.

Dantrium® is a registered trademark of Par Sterile Products, LLC.

© 2015 PSPB04 0215

2015-2016

th Corporate

28

ANNUAL

Profiles

PHARMEDIUM U Transforming Medication Delivery™

A

t PharMEDium, we are committed to patient safety. Count on PharMEDium to provide sterile preparations with the highest levels of quality assurance and patient safety in mind. From the use of FDA-approved sterile components to proven leadership in R&D, quality, labeling/packaging and service, you can expect us to deliver the highest-quality compounded sterile preparations to our customers.

As the leading provider of compounded sterile preparations for more than a decade, PharMEDium has been an advocate for you and your patients. PharMEDium was among the first entities to voluntarily register with the U.S. Food and Drug Administration (FDA) as a Human Drug Compounding Outsourcing Facility under Section 503B of the Federal Food, Drug and Cosmetic Act. PharMEDium provides compounded sterile preparations to hospital pharmacies and surgery centers as an extension of their sterile preparation for IV and epidural therapy requirements, using FDA-approved sterile drugs and FDA-cleared sterile containers.

PharMEDium helps meet the demands placed on hospitals and surgery centers to ensure patients receive their medications on time and as prescribed. It is our mission to be the preeminent provider of choice for our customers and to attain the highest degree of integrity in the compounding of sterile preparations.

AT A GLANCE Two Conway Park 150 North Field Drive, Suite 350 Lake Forest, IL 60045 (800) 523-7749 www.pharmedium.com

CHIEF EXECUTIVE OFFICER William R. Spalding

SERVICES Delivering only the highest-quality, readyto-use compounded sterile preparations for use within the medical triad of care.

Pain management PCAs and epidurals; labor and delivery; nerve block and local anesthetics; OR anesthesia syringe preparations; ICU services.

Labeling Our complete and total commitment to advancing patient safety is embodied through first-in-class labeling, packaging and cutting-edge barcode scanning technology designed to help reduce the potential for medication errors.

Service As a PharMEDium customer, you deserve the highest level of quality and the highest level of service. That’s why we assign a team of professionals to each customer.

Our team will supply what you need—from the emergency room to the operating room to the patient’s room.

Electronic DEA Form 222 (CSOS) ordering at pharmedium.com makes ordering easy, convenient and reliable. Additionally, an online order status and invoice preview means you can get your questions answered with a few simple clicks of the mouse.

P10666

32

Anesthesiology News • August 2015

This corporate profile was reviewed and approved by PharMEDium.

CONTROL THE PAIN

CONTROL THE PAIN – and complexity of compliance with state and federal regulations for compounded sterile drug preparations.

• Benefit from our industry-leading labeling and packaging, which helps to ensure accuracy all the way to the point of care • Manage critical drug shortages with our allocation services • Rely on 24/7 Access to Customer Service and online ordering to manage your medication needs • Reduce waste with Ropivacaine and Bupivacaine ready to use compounded services*

Call (800) 523-7749 or visit pharmedium.com to learn how PharMEDium can help you

CONTROL THE COMPLEXITY OF COMPLIANCE.

Transforming medication delivery™.

*Kellner A, Fortier CR, Weber J, Guidry OF, “Outsourced pre-filled syringe system conversion: an assessment of OR IV waste reduction and clinical satisfaction”.

AM Soc of Health Syst Pharmacists Mid-Year Clinical meeting, Anaheim, CA, 2010.

Any intellectual property rights to the names, logos or materials depicted in this document not owned by PharMEDium are those of their respective owners, and PharMEDium does not claim any ownership to such intellectual property.

PharMEDium is an FDA-registered, 503B compounding outsourcing facility.

P10601_R2 © PharMEDium Services, LLC 2015

PharMEDium has a proven reputation for stringent regulatory compliance – delivering the highest levels of quality assurance for ready to use sterile preparations – ALL WITH YOUR PATIENT’S SAFETY IN MIND.

2015-2016

th Corporate

28

ANNUAL

Profiles

SSPACELABS C S HEALTHCARE C

S

pacelabs Healthcare is a comprehensive, perioperative solutions provider developing, manufacturing and distributing medical equipment and services throughout the world. We provide solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories, selling to hospitals, clinics and physician offices. Spacelabs’ world headquarters, in Snoqualmie, Wash., is where we develop and assemble anesthesia, patient monitoring and cardiology products.

Spacelabs provides various perioperative solutions from low to high acuity, covering simple to complex cases and pediatric to geriatric patients—offering you the choices you need in anesthesia delivery, patient monitoring and supplies and accessories. What’s more, you can configure solutions to satisfy your individual practices and preferences. Our product line is continually developing and expanding with new platforms and technologies.

Spacelabs Healthcare has more than 50 years of innovation and service, and began as the innovator of life support systems for the Gemini and Apollo space missions. Always endeavoring to meet our customer’s unmet needs, the result is the complete rethinking of the anesthesia delivery system experience.

Welcome to ARKON Until today, anesthesia delivery systems were designed with functionality and reliability as the priority. While important, we saw these as our starting point.

ARKONTM is our “evolutionary” anesthesia delivery system that pushes the boundaries to provide advanced flexibility and ergonomics for you, the people who use these machines.

ARKON puts your patient front and center—offering anesthesiologists the maximum in functionality, comfort and control. Through a combination of an expandable clinical console, which extends out to enable a wideangle view of your clinical setting, and enhancements not previously available in the perioperative environment, we focused ARKON on you, so you can focus on your patient. While other machines concentrate only on the technology of anesthesia delivery, we believe you will find ARKON unique in its attention to the details of how you work. Providing you with an improved workplace was our priority, with flexibility our focus. Designed to improve the user experience, ARKON is part of our mission to inspire the world to bring the best care to patients as well as their families.

Spacelabs Healthcare is dedicated to developing and supporting those tools.

Spacelabs Healthcare Collaborates With Clinicians To Provide Clinically Relevant Products Spacelabs Healthcare values the strong clinical partnerships that we have developed and maintained over the past half-century. Through continuous and effective communication with clinical user groups, we gather a deep understanding of needs and requirements in order to develop solutions to help clinicians achieve their goals.

Always a leader in innovation with accessibility, continuity and partnership, Spacelabs Healthcare delivers on our promises to: • Help improve patient care.

• Help clinicians achieve their goals.

• Demonstrate honesty, reliability and integrity.

• Deliver quality products and service, service, service.

AT A GLANCE 35301 SE Center St. Snoqualmie, WA 98065 (425) 396-3300 www.spacelabshealthcare.com marketing@spacelabs.com

PRESIDENT Nicholas Ong

When selecting a perioperative solutions company, consider Spacelabs’ experience and heritage of innovative and intuitive products developed in partnership with our customers to address real-life clinical needs.

Our customer-first philosophy reflects our commitment to superior care for you and your patients as well as product support by our award-winning service team.

Excellence in Customer Service and Support At Spacelabs Healthcare, excellence in customer service and support are not just words; they are values, embraced by all our employees, that shape the way that we do business. As a result, IMV ServiceTrak™, one of the most respected surveys in the health care industry, ranked Spacelabs “Best for Overall Service Performance among Industry Peers” in 2011 for the second consecutive year, and three of the last seven years.

We work cooperatively to develop long-term relationships with our suppliers, our distribution partners and our customers to provide the products, tools and services you need. Spacelabs is a focused, agile organization that is here to serve health care professionals worldwide. Our goal is to provide our customers more time to care. Customer loyalty is our reward.

“The Spacelabs Advantage” For more than 50 years, health care professionals have experienced the company’s proven commitment to connecting innovation with care; stability for a strong future; collaboration with clinical and technological partners; effective implementation of real-world solutions; and service wherever, whenever and however it’s needed. The most important factor in patient care is a knowledgeable medical professional with the right tools.

34

Anesthesiology News • August 2015

This corporate profile was reviewed and approved by Spacelabs Healthcare.

COST OF OWNERSHIP It is not just the purchase price.

THE PURCHASE PRICE IS ONE THING. The cost of maintaining a machine is another, and often, a variable not discussed upfront. When you buy an ARKON, this won’t be a surprise.

The cost of ownership over 10 years is $1300 or less per machine!

Serviceability was considered as part of the design process of the ARKON and it shows. t Single annual maintenance; minimal service time. t Improved reliability. t Simple setup. t Low cost maintenance. t 24/7 Technical Support.

It’s simple. ARKON offers more for less.

ARKON stands alone.

l marketing@spacelabs.com

*(), KhY[]dYZk @]Ydl`[Yj] Kh][aÚ[Ylagfk kmZb][l lg [`Yf_] oal`gml fgla[]&

2015-2016

th Corporate

28

ANNUAL

Profiles

TEAMHEALTH ANESTHESIA S S

T

eamHealth Anesthesia is a nationally recognized provider of comprehensive anesthesiology services. Our proven quality and service platform is specifically designed to optimize quality of care, patient and surgeon satisfaction, and operational efficiency.

TeamHealth’s 35 years of success in providing local physician partners is built on supporting our providers so they can concentrate on taking care of every patient they see and supporting success in each department we serve. TeamHealth providers care for more than 12 million patients per year, giving us the expertise to hardwire both clinical and operational best practices.

With extensive experience as providers in all anesthesiology services, business managers and hospital/medical staff leaders, the TeamHealth Anesthesia leadership team is unsurpassed in helping improve the performance of their anesthesiology and perioperative medicine departments. Whether augmenting an existing anesthesia group or forming a new one, TeamHealth Anesthesia provides customized solutions and first-rate specialists.

In fact, we are industry leaders in anesthesiology: • Surgeon satisfaction • Quality and metric performance, measurement and reporting • Patient safety and risk management • Recruitment and retention of anesthesiologists and anesthetists • Operating room efficiency • Leadership development • Group management and leadership • Billing, collections and credentialing

Your Career Will Thrive With TeamHealth Anesthesia Founded by anesthesiologists, TeamHealth Anesthesia uniquely understands the needs and expectations of anesthesiologists and anesthetists. Our solid reputation in the provider community allows us to partner with the best anesthesia clinicians in the market, creating stable, quality-driven groups for our hospital and surgeon partners. To continue our success, we need leading clinicians like you to be part of our team.

Coast-to-Coast Opportunities Your perfect practice is waiting for you at TeamHealth Anesthesia. We have practices throughout the United States, so whether you’re looking for cities, suburbs, mountains or beaches, we have the practice you want,

36

Anesthesiology News • August 2015

where you want, just waiting for you to make it your own. Our partner hospitals range from community hospitals in comfortable bedroom townships to major medical centers and teaching facilities in urban areas. With a wide variety of practice environments and case mixes, as well as varying anesthesia delivery models—from direct anesthesia care to anesthesia care teams—you’ll find opportunities to:

AT A GLANCE 7111 Fairway Dr., Ste. 450 Palm Beach Gardens, FL 33418 (877) 799-3552 anesthesiajobs@teamhealth.com www.teamhealth.com

SERVICES

• Nurture your professional interests while advancing your career.

• Receive a highly competitive salary with benefits and performance incentives.

• Choose from coast-to-coast nationwide practice opportunities.

• Practice medicine without the daily burdens of managing a practice.

• Focus on what matters most to you—patient care.

Best of all, when you’re part of our “team,” we’ll provide unparalleled resources that will help you be one of the best anesthesiology professionals in the nation. Through timely risk management and our leadership skills education programs like LEAD™, the TeamHealth Leadership Development Institute™ and others, you’ll discover that we care as much about your career and quality of life as you do.

TeamHealth Anesthesia is one of the nation’s leading outsourced anesthesiology and pain management service organizations—specializing in delivering high-quality, cost-effective and service-focused patient care.

• •

•

Anesthesia Care Team Anesthesiology programs nationwide are moving from the physician-only anesthesia service delivery models to mixed-care team models with both physicians and anesthetists. TeamHealth Anesthesia has extensive experience in the anesthesia care team (ACT) model and has successfully transitioned numerous physician-only models to ACT models. Our experience has shown us that the benefits of the ACT model include improved practice efficiencies, standardization of care, flexibility, and increased patient and surgeon satisfaction.

Always sensitive to the needs of surgeons and the hospitals we serve, TeamHealth Anesthesia implements the following transition activities with minimal disruption to the existing anesthesia program: • Recruit anesthesia medical directors who possess a strong customer service mindset; support their respective hospital’s vision and goals; communicate with surgeons to ensure mutual understanding of the ACT model to be implemented; have experience

• •

working with anesthetists; and create positive group cultures.

Recruit and retain a core group of physicians and anesthetists.

Provide team-building workshops with anesthesia providers, surgical leadership and the hospital executive team.

Appoint an internal chief anesthetist to help physicians and anesthetists work as a team.

Leverage TeamHealth’s national customer service training programs to improve satisfaction scores.

Implement daily anesthesia “team huddles” to ensure all processes are properly in place for surgeries and patients scheduled for the next day.

By implementing the ACT model, our client hospitals see faster room turnovers as well as drastically improved efficiency and reduced costs.

The Right Job. The Right Place.

The Right Partner.

TeamHealth Anesthesia is one of the nation’s leading outsourced anesthesiology organizations. Specializing in delivering high-quality, cost-effective and servicefocused patient care, our services maximize operating room performance while increasing patient and surgeon satisfaction.

For more information, visit us online at www. teamhealth.com, call (877) 799-3552, or email anesthesiajobs@teamhealth.com.

This corporate profile was reviewed and approved by TeamHealth Anesthesia.

An opportunity to follow my passion. “ I enjoy academics, and TeamHealth supports my interest in helping train med students rotating through the hospital. Also, I have an appreciation for informatics and the role it plays in patient safety and care. r TeamHealth supported me in my pursuit to secure my certification in an enterprise electronic medical records system which allows me to participate in building some of the systems. TeamHealth does such a good job of taking care of our practice administration details that, even with my extra duties, I still have plenty time to have an active outdoor lifestyle.”

— Johann Santa-Eulalia, M.D. Martin Health System, Stuart, FL

Featured Opportunities: Fawcett Memorial Hospital Port Charlotte, FL Englewood Hospital & Medical Center Englewood, NJ Legacy Good Samaritan Hospital & Medical Center Portland, OR 888.861.4093 | www.teamhealth.com | anesthesiajobs@teamhealth.com

2015-2016

th Corporate

28

ANNUAL

Profiles

TELEFLEX

T

eleflex believes in improving the health and quality of people’s lives. We apply purpose-driven innovation—a relentless pursuit of identifying unmet clinical needs—in a way that benefits patients, providers and society. Our Arrow®, Hudson RCI®, LMA® and Rusch® brands shape our portfolio of proven medical products and technologies. These distinguished brands are united by their common sense of purpose in providing anesthesia and respiratory therapy solutions that build, nurture and strengthen the vital parts at the heart of health care.

LMA® Airway Management The LMA® Airway Management family of products from Teleflex has a proven track record of safety and efficacy, building on a 20-year history of innovation and trust. Each LMA® Airway has been carefully designed and tested to meet exacting standards. LMA® Airways are included in the American Heart Association® Guidelines for Resuscitation and the American Society of Anesthesiologists® Difficult Airway Algorithm.

The LMA® Airway portfolio now includes offerings with Cuff Pilot™ technology, the original integrated cuff pressure indicator. This novel technology is a single-use device and provides constant inside-the-cuff pressure indication, allowing for at-a-glance clinical assessments.

In addition, the robust airway portfolio now offers a full range of single-use silicone laryngeal masks. Also featured is the LMA Supreme® Airway, which combines the best features of all previous LMA Airways to offer the highest degree of safety and ease of use. Whether for a routine procedure or to manage a higher-risk patient, the higher seal pressure and gastric access provvide a higher degree of safety. The LMA Suprreme® Airway is designed to channel fluidss away from the airway in the unlikely event of active or passive regurgitation and allows for diagnostic testing and verifiable positioning.

Needle-Free Solutions for Drug Delivery The LMA® Atomization family of products from Teleflex provides a simple-to-use, needle-free delivery solution for use with drugs approved for intranasal and/or oropharyngeal delivery. The LMA® MAD Nasal™ Intranasal Mucosal Atomization Device is the safe and painless choice that offers quick absorption across mucosal membranes to the bloodstream. The LMA® MADgic® Laryngotracheal Mucosal Atomization Device is a versatile choice to administer medication across the entire upper airway and beyond the vocal cords. The LMA® MADgic Airway™ Intubating Airway with Mucosal Atomization and Oxygen Delivery is an innovative choice to create a temporary airway to facilitate fiber-optic intubation, combining atomized topical anesthetic and oxygen delivery in an innovative and elegantly designed oral airway.

38

Anesthesiology News • August 2015

Post-Op Pain Management Solutions For most patients, postoperative pain is their primary concern before surgery, and nearly 80% of patients who experience postoperative pain report experiencing moderate to extreme pain.1 This is why every day we challenge the status quo by offering practical pain management solutions to deliver positive outcomes for the patient and provider.

Continuous peripheral nerve blocks have been proven to offer superior postoperative analgesia and improve patient satisfaction compared with opioids, while resulting in fewer minor complications, including nausea/vomiting, pruritus and sedation.2 The Arrow® FlexBlock® Echogenic Continuous Peripheral Nerve Block (CPNB) Catheter and the Arrow® AutoFuser® Disposable Pain Pump from Teleflex allow clinicians to combine efficient and accurate catheter placement with a reliable, unimpeded infusion of medication. The Arrow® FlexBlock® CPNB Catheter is an echogenic, flexible, kink-resistant catheter designed to help clinicians better control patient pain and improve overall block success. The Arrow® AutoFuser® Disposable Pain Pump offers the right pain pump to meet a variety of clinical demands, allowing clinicians to provide individualized patient pain control and adjust therapy as needed.

Enabling Greater Access to Video Laryngoscopy The Rusch® Airtraq™ Avant™ Video Laryngoscope System provides users with an affordable video solution when and where it is needed. The system allows clinicians to project what they are seeing during intubation on a number of different platforms through a WiFi connection. This allows the clinician to share his or her view with others, and increases visibility while intubating. The convenience of the Rusch® Airtraq™ Avant™ Video Laryngoscope System is that it requires little in the way of capital expenditures and allows clinicians to reuse the optics. The image can be projected up to 50 times before replacement. The Airtraq™ Avant™ Blades, which are available in two sizes, are fully disposable to reduce the risk for crosscontamination, enhancing patient safety.

Reducing Cross-Contamination, Reducing Cost The risk for cross-contamination during intubation of the trachea exists because no perfect procedure for decontamination exists.3 Single-use devices offer the opportunity to reduce potential for infection associated with reusable devices.

Green Rusch Lite™ and Rusch® EquipLite® Disposable Metal Laryngoscope Blades are single-use blades that offer users the performance and feel of a reusable metal blade. These blades eliminate the hassles associated with reusable blades, such as the time and cost of

AT A GLANCE 550 E. Swedesford Rd., Suite 400 Wayne, PA 19087

EMPLOYEES More than 11,000

CHIEF EXECUTIVE OFFICER Benson Smith

reprocessing, without sacrificing stren ngth or light quality.

The Rusch® DispoLED® Single-Usee Fiber Optic Laryngoscope Handle is a reliable way to combat intubation infecction risk. With its ISO 7376 complian nt fittings, the green handle of the Rusch® DispoLED D® Device can also be safely integrated with other com mpatible fiber optic/green systems in use in the hospital. pital.

Reducing Waste Anesthetic Gas (WAG) Exposure in the PACU An invisible risk exists in the postanesthesia care unit (PACU). Patients may exhale waste anesthetic gas (WAG) into the breathing zone of attending nurses.4 Although WAG cannot be detected by sight or odor, PACU clinicians can take action to protect themselves from the potential health effects.

The first of its kind on the market, the ISOGard® Mask with ClearAir™ Technology from Teleflex was developed in partnership with clinicians who identified the issue and wanted to take action. As the only solution currently available for source control of WAG in the PACU, the ISO-Gard® Mask scavenging system simultaneously delivers oxygen to patients and scavenges their exhalation to help limit exposure faced by clinicians and minimize the cumulative effect of low-level exposure to WAG.

References 1. Warfield, CA, et al. Acute pain management: Programs in U.S. hospitals and experiences and attitudes among U.S. adults. Anesthesiology.

1995;83(5):1090-1094.

2. Richman JM, et al. Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesth Analg.

2006;102(1): 248-257.

3. Galinski M, et al. Disposable laryngoscope blades do not interfere with ease of intubation in scheduled general anesthesia patients. Eur J Anaesthesiol. 2003;20(9):731-735.

4. Occupational Safety and Health Administration, U.S. Department of Labor. Anesthetic Gases: Guidelines for Workplace Exposures. Revised May 18. 2000. http://www.osha.gov/dts/osta/anestheticgases/index. html. Accessed June 10, 2015.

American Heart Association is a trademark or registered trademark of American Heart Association, Inc. American Society of Anesthesiologists is a trademark or registered trademark of ASA Corporation.

AutoFuser is a trademark or registered trademark of Ace Medical Co., Ltd. Airtraq and Avant are trademarks or registered trademarks of Prodol Meditec S.A. Teleflex, Arrow, ClearAir, Cuff Pilot, DispoLED, EquipLite, FlexBlock, Green Rusch Lite, Hudson RCI, ISO-Gard, LMA, LMA Supreme, MAD, MAD Nasal, MADgic, MADgic Airway and Rusch are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.

MC-001308

This corporate profile was reviewed and approved by Teleflex.

At TELEFLEX... We believe in improving the health and quality of people’s lives.

P R O D U C T S

Y O U

T R U S T .

W H E N

Y O U

N E E D

T H E M .

By housing the brands you rely on under one roof, Teleflex is building, nurturing, and strengthening the vital parts at the heart of healthcare innovation.

LMA® L

®

Arrow A

MADgic M

®

AutoFuser A

®

Disposable Pain Pump D

Laryngo-Tracheal Mucosal L A Atomization Device*

POST-OP PAIN HAS P MET M ITS MATCH

I IDEAL FOR YOUR DIFFICULT AND AWAKE INTUBATIONS A

LMA Supreme L

Rusch Airtraq Avant

Airway A

Video Laryngoscope System

O OUR MOST ADVANCED SECOND GENERATION AIRWAY S

A SOLUTION FOR GUIDED VIDEO INTUBATION V

®

®

™

™

FOR MORE INFORMATION OR TO PLACE AN ORDER, CALL US AT 866.246.6990 OR VISIT MYTELEFLEXORDER.COM

WWW.TELEFLEXARCATALOG.COM *For use with drugs approved for oropharyngeal delivery

AutoFuser and AutoSelector are trademarks or registered trademarks of ACE Medical Co., Ltd. Airtraq and Avant are trademarks or registered trademarks of Prodol Meditec S.A. Teleflex, Arrow, LMA, LMA Supreme, MAD, MADgic and Rusch are trademarks or registered trademarks of Teleflex Incorporated or its affiliates. © 2015 Teleflex Incorporated. All rights reserved. MC-001397

Download the app from the best-read anesthesiology publication in the United States

@anesthesianews anesthesiologynews +anesthesiologynews

Register for the free e-Newsletter @ anesthesiologynews.com/enews

Optimized for mobile devices

Always available online